Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

103 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of methotrexate dosing protocols for graft-versus-host disease prophylaxis after unrelated hematopoietic stem cell transplantation.
Nakamura N, Kanda J, Kondo T, Kitano T, Ikeda T, Imada K, Takaya R, Kubo T, Mitsuyuki S, Oka S, Yonezawa A, Takeoka T, Akasaka T, Hishizawa M, Yago K, Tsunemine H, Watanabe M, Itoh M, Takaori-Kondo A; Kyoto Stem Cell Transplantation Group (KSCTG). Nakamura N, et al. Among authors: hishizawa m. Cytotherapy. 2024 Nov 17:S1465-3249(24)00935-6. doi: 10.1016/j.jcyt.2024.11.009. Online ahead of print. Cytotherapy. 2024. PMID: 39652019
Mycophenolate mofetil combined with tacrolimus and minidose methotrexate after unrelated donor bone marrow transplantation with reduced-intensity conditioning.
Mizumoto C, Kanda J, Ichinohe T, Ishikawa T, Matsui M, Kadowaki N, Kondo T, Imada K, Hishizawa M, Kawabata H, Nishikori M, Yamashita K, Takaori-Kondo A, Hori T, Uchiyama T. Mizumoto C, et al. Among authors: hishizawa m. Int J Hematol. 2009 May;89(4):538-545. doi: 10.1007/s12185-009-0306-5. Epub 2009 Apr 11. Int J Hematol. 2009. PMID: 19363648
High pretransplant hepcidin levels are associated with poor overall survival and delayed platelet engraftment after allogeneic hematopoietic stem cell transplantation.
Sakamoto S, Kawabata H, Kanda J, Uchiyama T, Mizumoto C, Kitano T, Kondo T, Hishizawa M, Tomosugi N, Takaori-Kondo A. Sakamoto S, et al. Among authors: hishizawa m. Cancer Med. 2017 Jan;6(1):120-128. doi: 10.1002/cam4.974. Epub 2016 Dec 1. Cancer Med. 2017. PMID: 27905193 Free PMC article.
Impact of the Use and Type of Antibiotics on Acute Graft-versus-Host Disease.
Nishi K, Kanda J, Hishizawa M, Kitano T, Kondo T, Yamashita K, Takaori-Kondo A. Nishi K, et al. Among authors: hishizawa m. Biol Blood Marrow Transplant. 2018 Nov;24(11):2178-2183. doi: 10.1016/j.bbmt.2018.06.031. Epub 2018 Jul 3. Biol Blood Marrow Transplant. 2018. PMID: 30417828 Free article.
Impact of Donor Source on Allogeneic Hematopoietic Stem Cell Transplantation for Mature T Cell and Natural Killer Cell Neoplasms in the Kyoto Stem Cell Transplantation Group.
Watanabe M, Kanda J, Arai Y, Hishizawa M, Nishikori M, Ishikawa T, Imada K, Ueda Y, Akasaka T, Yonezawa A, Nohgawa M, Kitano T, Itoh M, Takeoka T, Moriguchi T, Yago K, Arima N, Anzai N, Watanabe M, Kondo T, Takaori-Kondo A; Kyoto Stem Cell Transplantation Group (KSCTG). Watanabe M, et al. Among authors: hishizawa m. Biol Blood Marrow Transplant. 2020 Dec;26(12):2346-2358. doi: 10.1016/j.bbmt.2020.07.032. Epub 2020 Jul 30. Biol Blood Marrow Transplant. 2020. PMID: 32738500 Free article.
High-dose cytarabine chemotherapy (≥4 g/m2/day) before allogeneic hematopoietic stem cell transplantation for non-core-binding-factor AML in the first complete remission.
Nagahata Y, Kondo T, Ono Y, Hiramoto N, Kitano T, Hishizawa M, Yamashita K, Hashimoto H, Ishikawa T, Takaori-Kondo A. Nagahata Y, et al. Among authors: hishizawa m. Leuk Lymphoma. 2020 Dec;61(13):3128-3136. doi: 10.1080/10428194.2020.1805112. Epub 2020 Aug 17. Leuk Lymphoma. 2020. PMID: 32804016
103 results